EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Suspected Donor-derived Myeloid Neoplasia After Allogeneic HSCT: A Case-based Review of Clonal Evolution

Giuseppe Mirabile, Roberto Bono, Adele Bottaro, Fabio Stagno, Giuseppe Coppolino, Manlio Fazio, Luca Castagna, Alessandro Allegra

In Vivo · 2026-11 · 40 (6) · 3900-3911

DOI: 10.21873/invivo.14527 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift In Vivo, online erschienen am 29.10.2026. Verfasst von Giuseppe Mirabile und 7 weiteren Autor:innen. Beteiligte Einrichtung: Hematology Unit, Department of Human Pathology in Adulthood and Childhood "Gaetano Barresi", University Hospital "G. Martino" Messina, Messina, Italy. Hauptthemen laut MEDLINE: Clonal Evolution, Hematopoietic Stem Cell Transplantation, Leukemia, Myeloid, Acute, Tissue Donors. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND/AIM: Donor-derived leukemia represents a rare but increasingly recognized clinical complication of allogeneic hematopoietic stem cell transplantation. Emerging evidence indicates that clonal hematopoiesis of indeterminate potential in donors provides the biological substrate for donor-derived leukemia, while post-transplant immune pressure and niche damage drive clonal selection and leukemic evolution. CASE REPORT: We describe the case of a 70-year-old woman with acute myeloid leukemia who underwent matched unrelated donor allogeneic hematopoietic stem cell transplantation (allo-HSCT) from a 25-year-old female donor. Following transplantation, serial bone marrow examinations demonstrated persistent predominant donor chimerism accompanied by progressive expansion of an aberrant myeloid population, increasing from approximately 2% to 14% by multiparametric flow cytometry, without clear morphologic relapse. Targeted next-generation sequencing at hematologic progression identified a pathogenic RAS-pathway mutation with a variant allele frequency of 7%, while no molecular features overlapping with the initially characterized acute myelogenous leukemia (AML) were identified. However, pre-transplant next-generation sequencing (NGS) data from both donor and recipient and lineage-specific chimerism of the abnormal population were unavailable, preventing definitive demonstration of donor origin. CONCLUSION: This case represents a suspected donor-derived myeloid neoplasm arising after allo-HSCT and illustrates the diagnostic difficulty of distinguishing donor-derived disease from relapse and other post-transplant myeloid neoplasms. The case also highlights the potential value of integrating serial flow cytometry, molecular profiling, and lineage-specific chimerism analyses when unexplained cytopenias or progressive abnormal myeloid populations develop despite preserved donor chimerism. The proposed evolutionary and microenvironmental mechanisms should be considered hypothesis-generating and require further validation in molecularly characterized cases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Clonal EvolutionHematopoietic Stem Cell TransplantationLeukemia, Myeloid, AcuteTissue DonorsAgedFemaleHumansHigh-Throughput Nucleotide SequencingMutationTransplantation, HomologousCase Reports as Topic

Stichwörter der Autor:innen

Donor-derived leukemiaallogeneic hematopoietic stem cell transplantationbone marrow chimerismbone marrow nicheclonal evolutionclonal hematopoiesis of indeterminate potential (CHIP)immune selection

Autor:innen und Institutionen

  • Hematology Unit, Department of Human Pathology in Adulthood and Childhood "Gaetano Barresi", University Hospital "G. Martino" Messina, Messina, Italy.
  • Bone Marrow Transplant Unit, Azienda Ospedaliera Ospedali Riuniti Villa Sofia Cervello, Palermo, Italy.
  • Hematology Unit, Department of Human Pathology in Adulthood and Childhood "Gaetano Barresi", University Hospital "G. Martino" Messina, Messina, Italy; aallegra@unime.it.

Zitieren

APA

Mirabile, G., Bono, R., Bottaro, A., Stagno, F., Coppolino, G., Fazio, M., Castagna, L., & Allegra, A. (2026). Suspected Donor-derived Myeloid Neoplasia After Allogeneic HSCT: A Case-based Review of Clonal Evolution. In Vivo, 40(6), 3900-3911. https://doi.org/10.21873/invivo.14527

Vancouver

Mirabile G, Bono R, Bottaro A, Stagno F, Coppolino G, Fazio M, et al. Suspected Donor-derived Myeloid Neoplasia After Allogeneic HSCT: A Case-based Review of Clonal Evolution. In Vivo. 2026;40(6):3900-3911. doi:10.21873/invivo.14527

BibTeX
@article{Mirabile2026,
  author = {Mirabile, Giuseppe and Bono, Roberto and Bottaro, Adele and Stagno, Fabio and Coppolino, Giuseppe and Fazio, Manlio and Castagna, Luca and Allegra, Alessandro},
  title = {Suspected Donor-derived Myeloid Neoplasia After Allogeneic HSCT: A Case-based Review of Clonal Evolution},
  journal = {In Vivo},
  year = {2026},
  volume = {40},
  number = {6},
  pages = {3900--3911},
  doi = {10.21873/invivo.14527}
}
Kostenlos starten →